Title of article :
Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade
Author/Authors :
Shelley A. Hall، نويسنده , , Carlos G. Cigarroa، نويسنده , , Lucille Marcoux، نويسنده , , Richard C. Risser، نويسنده , , Paul A. Grayburn، نويسنده , , Eric J. Eichhorn، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 1995
Abstract :
Objectives.
We examined the time course of ventricular functional improvement in patients with dilated cardiomyopathy who received beta-blockade and the long-term effects of beta-blockade on ventricular mass and geometry in these patients.
Background.
Previous studies have shown that beta-adrenergic blocking agents when administered long term improve ventricular function in patients with heart failure. However, the time course of improvement in ventricular function and the long-term effects of beta-blockade on ventricular mass and geometry are not known.
Methods.
Twenty-six men with dilated cardiomyopathy underwent serial echocardiography on days 0 and 1 and months 1 and 3 of either metoprolol (n = 16) or standard therapy (n = 10). At 3 months all patients on standard therapy were crossed over to metoprolol, and late echocardiograms were obtained after 18 ± 5 (mean ± SD) months of metoprolol therapy. All echocardiograms were read in blinded manner.
Results.
Patients treated with metoprolol had an initial decline (day 1 vs. day 0) in ventricular function (increase in end-systolic volume and decrease in ejection fraction). Ventricular function improved between months 1 and 3 (p = 0.013, metoprolol vs. standard therapy). Left ventricular mass regressed at 18 months (333 ± 85 to 275 ± 53 g, p = 0.011) but not at 3 months. Left ventricular shape became less spherical and assumed more normal elliptical shape by 18 months (major/minor axis ratio 1.5 ± 0.2 to 1.7 ± 0.2, p = 0.0001).
Conclusions.
Patients with heart failure treated with metoprolol do not demonstrate an improvement in systolic performance until after 1 month of therapy and may have mild reduction in function initially. Long-term therapy with metoprolol results in reversal of maladaptive remodeling with reduction in left ventricular volumes, regression of left ventricular mass and improved ventricular geometry by 18 months.
Journal title :
JACC (Journal of the American College of Cardiology)
Journal title :
JACC (Journal of the American College of Cardiology)